Literature DB >> 18982407

Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications.

R J Collighan1, M Griffin.   

Abstract

This review summarises the functions of the enzyme tissue transglutaminase (TG2) in the extracellular matrix (ECM) both as a matrix stabiliser through its protein cross-linking activity and as an important cell adhesion protein involved in cell survival. The contribution of extracellular TG2 to the pathology of important diseases such as cancer and fibrosis are discussed with a view to the potential importance of TG2 as a therapeutic target. The medical applications of TG2 are further expanded by detailing the use of transglutaminase cross-linking in the development of novel biocompatible biomaterials for use in soft and hard tissue repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982407     DOI: 10.1007/s00726-008-0190-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  53 in total

1.  RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.

Authors:  Zhuo Wang; Russell J Collighan; Stephane R Gross; Erik H J Danen; Gertraud Orend; Dilek Telci; Martin Griffin
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

2.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

Review 3.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

4.  Inhibition of transglutaminase activity in periodontitis rescues periodontal ligament collagen content and architecture.

Authors:  Emilie Moore Rosset; Jessica Trombetta-eSilva; Glenn Hepfer; Peng Chen; Hai Yao; Amy D Bradshaw
Journal:  J Periodontal Res       Date:  2019-09-25       Impact factor: 4.419

5.  Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression.

Authors:  Jiyoon Lee; Salvatore Condello; Bakhtiyor Yakubov; Robert Emerson; Andrea Caperell-Grant; Kiyotaka Hitomi; Jingwu Xie; Daniela Matei
Journal:  Clin Cancer Res       Date:  2015-06-03       Impact factor: 12.531

Review 6.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 7.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

Review 8.  Focus on molecules: transglutaminase 2.

Authors:  Tara Tovar-Vidales; Abbot F Clark; Robert J Wordinger
Journal:  Exp Eye Res       Date:  2010-06-25       Impact factor: 3.467

9.  Cell-Cell Mechanical Communication in Cancer.

Authors:  Samantha C Schwager; Paul V Taufalele; Cynthia A Reinhart-King
Journal:  Cell Mol Bioeng       Date:  2018-12-07       Impact factor: 2.321

10.  Transglutaminase-2 in cell adhesion: all roads lead to paxillin?

Authors:  Evelyn Png; Louis Tong
Journal:  Cell Adh Migr       Date:  2013-09-12       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.